Items where authors include "Morrell, N.W."

Article

Ulrich, A. orcid.org/0000-0003-3280-9974, Wu, Y., Draisma, H. orcid.org/0000-0001-6279-0368 et al. (23 more authors) (2024) Blood DNA methylation profiling identifies cathepsin Z dysregulation in pulmonary arterial hypertension. Nature Communications, 15 (1). 330. ISSN 2041-1723

Eichstaedt, C.A., Belge, C., Chung, W.K. orcid.org/0000-0003-3438-5685 et al. (8 more authors) (2023) Genetic counselling and testing in pulmonary arterial hypertension: a consensus statement on behalf of the International Consortium for Genetic Studies in PAH. European Respiratory Journal, 61 (2). 2201471. ISSN 0903-1936

Prapa, M., Lago-Docampo, M., Swietlik, E.M. et al. (37 more authors) (2022) First genotype-phenotype study in TBX4 syndrome : gain-of-function mutations causative for lung disease. American Journal of Respiratory and Critical Care Medicine. ISSN 1073-449X

Jones, R.J., De Bie, E.M.D.D., Groves, E. et al. (31 more authors) (2022) Autoimmunity Is a Significant Feature of Idiopathic Pulmonary Arterial Hypertension. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 206 (1). pp. 81-93. ISSN 1073-449X

Errington, N. orcid.org/0000-0001-6768-7394, Iremonger, J., Pickworth, J.A. orcid.org/0000-0002-7199-364X et al. (13 more authors) (2021) A diagnostic miRNA signature for pulmonary arterial hypertension using a consensus machine learning approach. EBioMedicine, 69. 103444. ISSN 2352-3964

Li, W., Long, L., Yang, X. et al. (20 more authors) (2021) Circulating BMP9 protects the pulmonary endothelium during inflammation-induced lung injury in mice. American Journal of Respiratory and Critical Care Medicine, 203 (11). pp. 1419-1430. ISSN 1073-449X

Howard, L.S.G.E., He, J., Watson, G.M.J. et al. (25 more authors) (2021) Supplementation with iron in pulmonary arterial hypertension : two randomized crossover trials. Annals of the American Thoracic Society, 18 (6). pp. 981-988. ISSN 2329-6933

Zhu, N., Swietlik, E.M., Welch, C.L. et al. (22 more authors) (2021) Rare variant analysis of 4241 pulmonary arterial hypertension cases from an international consortium implicates FBLN2, PDGFD, and rare de novo variants in PAH. Genome Medicine, 13 (1). p. 80. ISSN 1756-994X

Ulrich, A., Otero-Núñez, P., Wharton, J. et al. (8 more authors) (2020) Expression quantitative trait locus mapping in pulmonary arterial hypertension. Genes, 11 (11). 1247.

Rhodes, C.J., Otero-Núñez, P., Wharton, J. et al. (28 more authors) (2020) Whole blood RNA profiles associated with pulmonary arterial hypertension and clinical outcome. American Journal of Respiratory and Critical Care Medicine, 202 (4). pp. 586-594. ISSN 1073-449X

Sofianopoulou, E., Church, C., Coghlan, G. et al. (9 more authors) (2020) Deprivation and prognosis in patients with pulmonary arterial hypertension: missing the effect of deprivation on a rare disease? European Respiratory Journal, 56 (2). 1902334. ISSN 0903-1936

Arnold, N.D. orcid.org/0000-0002-4317-5738, Pickworth, J.A. orcid.org/0000-0002-7199-364X, West, L.E. et al. (24 more authors) (2019) A therapeutic antibody targeting osteoprotegerin attenuates severe experimental pulmonary arterial hypertension. Nature Communications, 10 (1). 5183. ISSN 2041-1723

Sofianopoulou, E., Kaptoge, S., Gräf, S. et al. (30 more authors) (2019) Traffic exposures, air pollution and outcomes in pulmonary arterial hypertension: A United Kingdom cohort study analysis. European Respiratory Journal, 53 (5). 1801429. ISSN 0903-1936

Rhodes, C.J., Batai, K., Bleda, M. et al. (118 more authors) (2019) Genetic determinants of risk in pulmonary arterial hypertension: international genome-wide association studies and meta-analysis. Lancet Respiratory Medicine, 7 (3). pp. 227-238. ISSN 2213-2600

Bohnen, M.S., Ma, L., Zhu, N. et al. (47 more authors) (2018) Loss-of-function ABCC8 mutations in pulmonary arterial hypertension. Circulation: Genomic and Precision Medicine, 11 (10). e002087. ISSN 2574-8300

Graf, S., Haimel, M., Bleda, M. et al. (62 more authors) (2018) Identification of rare sequence variation underlying heritable pulmonary arterial hypertension. Nature Communications, 9. 1416. ISSN 2041-1723

Hadinnapola, C., Bleda, M., Haimel, M. et al. (41 more authors) (2017) Phenotypic characterisation of EIF2AK4 mutation carriers in a large cohort of patients diagnosed clinically with pulmonary arterial hypertension. Circulation, 136 (21). pp. 2022-2033. ISSN 0009-7322

Rhodes, C.J., Ghataorhe, P., Wharton, J. et al. (18 more authors) (2017) Plasma Metabolomics Implicate Modified Transfer RNAs and Altered Bioenergetics in the Outcome of Pulmonary Arterial Hypertension. Circulation, 135 (5). pp. 460-475. ISSN 0009-7322

Hameed, A.G., Arnold, N.D., Chamberlain, J. et al. (12 more authors) (2012) Inhibition of tumor necrosis factor–related apoptosis-inducing ligand (TRAIL) reverses experimental pulmonary hypertension. The Journal of Experimental Medicine, 209 (11). 1919 - 1935. ISSN 0022-1007

Proceedings Paper

Middleton, J.T., Konganige, S., Dahaghin, P. et al. (11 more authors) (2020) Abstract 15636: Effect of COVID-19 Public Health Measures on Activity and Quality of Life in Patients With Pulmonary Arterial Hypertension. In: Circulation. Scientific Sessions, 15 Nov 2020, Virtual conference. American Heart Association , A15636.

Świetlik, E., Lutz, K.A., Greene, D. et al. (14 more authors) (2020) New rare variant associations with distinct phenotypes in patients with pulmonary arterial hypertension revealed with Bayesian inference. In: European Respiratory Journal. ERS International Congress 2020, 07-09 Sep 2020, Virtual. European Respiratory Society , p. 4459.